Our in vivo study with a conditional transgenic mouse model allowing Has2 overexpression in breast cancer demonstrated that HA overproduction caused rapid development of aggressive breast carcinoma at a high incidence (40). The gene discussed is HAS2; the disease is breast carcinoma.